<?xml version='1.0' encoding='utf-8'?>
<document id="32237495"><sentence text="[Discovery of cytochrome P450 enzymes-inhibiting components in traditional Chinese medicine]." /><sentence text="With the widespread use of traditional Chinese medicine(TCM) and the integration of TCM and western medicine, drug-drug interaction(DDI) is considered as a major cause of therapeutic failures and side effects" /><sentence text=" Cytochrome P450 enzymes(CYPs) are responsible for large number of drug metabolism" /><sentence text=" CYP3 A4 and CYP2 D6, two important CYP isoforms, are responsible for about 80% drug metabolism of CYPs super family" /><sentence text=" The inhibition of CYPs is likely to be the most common factor leading to adverse DDI" /><sentence text=" Therefore, it is of great significance to predict potential CYP3 A4 and CYP2 D6 inhibitors to prevent the DDI" /><sentence text=" A fast and low-cost me-thod for calculating and predicting CYP inhibiting components was established in this paper, namely support vector machine(SVM) and molecular docking technology which are used to predict and screen drugs" /><sentence text=" Firstly, 12 qualitative models of two targets were established by using SVM, and the optimal model was selected to predict the compounds in traditional Chinese medicine database(TCMD)" /><sentence text=" Then, molecular docking technology was used to establish docking model" /><sentence text=" By analyzing the key amino acids involved in drug-target interactions and combining with SVM model, potential inhibitors of CYP3 A4 and CYP2 D6 were found"><entity charOffset="22-33" id="DDI-PubMed.32237495.s10.e0" text="amino acids" /></sentence><sentence text=" From the computational results, astin D and epiberberine exhibited inhibition effect on CYP3 A4 and CYP2 D6, respectively"><entity charOffset="33-40" id="DDI-PubMed.32237495.s11.e0" text="astin D" /><entity charOffset="45-57" id="DDI-PubMed.32237495.s11.e1" text="epiberberine" /><pair ddi="false" e1="DDI-PubMed.32237495.s11.e0" e2="DDI-PubMed.32237495.s11.e0" /><pair ddi="false" e1="DDI-PubMed.32237495.s11.e0" e2="DDI-PubMed.32237495.s11.e1" /></sentence><sentence text=" Astin D was only found in astins family from Aster tataricus, while epiberberine was considered to be the active constituent of Coptidis Rhizoma"><entity charOffset="1-8" id="DDI-PubMed.32237495.s12.e0" text="Astin D" /><entity charOffset="69-81" id="DDI-PubMed.32237495.s12.e1" text="epiberberine" /><pair ddi="false" e1="DDI-PubMed.32237495.s12.e0" e2="DDI-PubMed.32237495.s12.e0" /><pair ddi="false" e1="DDI-PubMed.32237495.s12.e0" e2="DDI-PubMed.32237495.s12.e1" /></sentence><sentence text=" Therefore, for the risk of DDI, extra attention should be paid to the source of these potential inhibitors, Asteris Radix et Rhizoma and Coptidis Rhizoma" /><sentence text=" This computational method provides technical support for discovering potential natural inhibitors of CYPs from Chinese herbs by using SVM and molecular docking model, and it is also helpful to recognize the CYPs-mediated DDI existing in TCM, providing research ideas for further pharmacovigilance of integrated therapy" /><sentence text="" /></document>